Stock Track | Precigen Soars 5.96% as H.C. Wainwright Raises Price Target to $9

Stock Track
2025/11/14

Precigen (PGEN) stock is soaring 5.96% in pre-market trading on Friday, following a bullish move by H.C. Wainwright. The investment firm has raised its price target on Precigen to $9 from $8.50, while maintaining a Buy rating on the shares.

The price target increase comes on the heels of Precigen's Q3 report. H.C. Wainwright's decision to boost its outlook for the stock suggests confidence in the company's recent performance and future prospects. This positive analyst action has sparked renewed interest in Precigen among investors, driving the stock's significant pre-market rally.

While specific details from the Q3 report that led to the upgraded price target were not provided, the maintained Buy rating indicates that H.C. Wainwright continues to see potential upside for Precigen. Investors will likely be watching closely for any further analyst commentary or company updates that could provide additional insights into Precigen's financial health and growth trajectory.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10